Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

AC Immune (Switzerland) | Researchclopedia

Back to institutions

AC Immune (Switzerland)

Lausanne, Vaudcompany

220

Works

27,812

Citations

85

h-index

Top Research Topics

Alzheimer's disease research and treatments Neuroscience and Neuropharmacology Research Dementia and Cognitive Impairment Research

Top Researchers

François Guilhot Inserm

625 works42,802 citationsh-index: 84

Recent Research

A transcriptomic microglia taxonomy across mouse and human pathologies

Chintan Chhatbar,Roman Sankowski,et al.

20260 citations

Cholinesterase and Neurodegenerative Diseases

Computational Drug Discovery Methods

Neuroinflammation and Neurodegeneration Mechanisms

Parkinson's Disease Mechanisms and Treatments

Neurological disorders and treatments

Mitochondrial Function and Pathology

Monoclonal and Polyclonal Antibodies Research

Epilepsy research and treatment

Immunotherapy and Immune Responses

Gian Luigi Gessa University of Cagliari

552 works27,718 citationsh-index: 87

Paolo Paganetti Ente Ospedaliero Cantonale

123 works19,048 citationsh-index: 45

Nicolas Toni Minia University

100 works14,386 citationsh-index: 49

Klemens Kaupmann Novartis (Switzerland)

128 works12,843 citationsh-index: 53

Burkhard Bechinger Centre National de la Recherche Scientifique

319 works12,493 citationsh-index: 61

Quantitative Systems Pharmacology Models of Anti‐Amyloid Treatments for Alzheimer's Disease: A Systematic Review

Lara Herriott,Mark Coles,et al.

20260 citations

Quantitative Systems Pharmacology Models of Anti‐Amyloid Treatments for Alzheimer’s Disease: A Systematic Review

Lara Herriott,Mark Coles,et al.

20250 citations

Development of [18F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology

Efthymia Vokali,Elodie Chevalier,et al.

20259 citations

Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study

Olivier Sol,Julien Mermoud,et al.

20253 citations

A single dose of a vectorized mAb targeting TDP-43 potently inhibits the neuropathology in a model of ALS/FTD

Greg del Val,Florence Gauye,et al.

20251 citations